News & events

PhosPrint selected as finalist for the SPIE Startup Challenge
December 12, 2022
Our consortium partner PhosPrint was selected as one of the finalists of the 13th annual SPIE Startup Challenge! The final pitch presentations will take placeÂ
M18 project meeting and first successful review
December 1, 2022
After 1.5 years of project implementation, the Tumor-LN-oC consortium recently gathered in Athens for the M18 project meeting. The 2-day consortium meeting w
Tumor-LN-oC at the Regenerative Medicine workshop 12.10. in Prague
July 20, 2022
Tumor-LN-oC partner AMIRES kindly invites you to the 2nd Regenerative Medicine workshop which will take place on Wednesday, October 12th 2022, in Prague. Reg
Working towards a Tumor-Lymph Node-On chip platform – Progress and achievements after 1 Year of Tumor-LN-oC
May 18, 2022
From 12-14 May 2022, the Tumor-LN-oC consortium met at TU/e in Eindhoven for the project’s M12 progress meeting. The Meeting officially concluded the first year
Tumor-LN-oC contribution to an innovative and resilient health industry in Europe highlighted for #WorldHealthDay
April 26, 2022
The European Health and Digital Executive Agency (HaDEA) has featured Tumor-LN-oC in a special article on its website for World Health Day. The agency underline
Laser bioprinting: a key technology for recapitulating tissue and cell functions
April 12, 2022
As one of the components of the Tumor-LN-oC platform, consortium partner PhosPrint is working on a laser bioprinting process for OrganOnChip (OoC) and sensor ap
Tumor-LN-oC at SPIE Photonics Europe 04.04.22
March 28, 2022
Tumor-LN-oC team member Symeon Papazoglou from PhosPrint is presenting his article “Laser bioprinting of cell-laden bioinks for organ-on-chip and sensor a
Tumor-LN-oC completes selection of materials and processes
March 25, 2022
With the conclusion of Month 10 of the project, Tumor-LN-oC consortium successfully passed the second milestone of the project: the final selection of specifica
Questionnaire for Tumor-LN-oC end-users
January 10, 2022
To better understand the end-user requirements for the tumor-lymph node-on-chip platform, that will be developed during the course of the project, we have prepa
6 months completed!
November 24, 2021
On the 18th and 19th of November, the Tumor-LN-oC consortium met for the M6 meeting in Athens. The meeting closed the first half year of project implementation